Abstract
Ontario shook up the world of generic drug pricing across the country 3 years ago when it passed Bill 102, the Transparent Drug System for Patients Act. In turn, the executive officer of Ontario’s $4-billion-a-year drug benefit plan saw her own life disrupted. In late April, Helen Stevenson was
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
